MAPT and Alzheimer disease: As a result, the past decade has witnessed a surge in research on the influence of the gut microbiome on AD pathogenesis which found that beta‐amyloid and tau burden associate with decreased gut microbial diversity in preclinical AD individuals (enteric dysbiosis or gut dysbiosis), suggesting altered gut‐brain signaling in AD.2, 3